Tetranectin, soluble P-selectin and VCAM-1 in the plasma of children with insulin-dependent diabetes mellitus

Fibrinolysis and Proteolysis

Volumn 13, Issue 3, 1999, Pages 148-153

  Kamper, E F ^a   Kopeikina, L T ^a   Karajiannis, Ch ^b   Gourgiotis, D ^b   Karpathios, Th ^b   Stavridis, J C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PADGEM PROTEIN; TETRANECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ALTERNATIVE RNA SPLICING; ARTICLE; BLOOD SAMPLING; CHILD; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HORMONE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; THROMBOCYTE ACTIVATION;

EID: 0032793943     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(99)90103-0     Document Type: Article

References (24)

1. Castano L, Eisenbarth GS. Type I diabetes: a chrome autoimmune disease of human mouse, and rat. Ann Rav Immunol 1990; 8: 647-679.
2. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalised by near-normoglycaemia. Diabetes 1995; 44: 890-894.
3. Wu KK, Thiagatajian P. Role of endothelium in thrombosis and hemostasis. Ann Rev Med 1996; 47: 315-331.
4. Knobl P, Scernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, Muller M. Thrombogenic factors are related to urinary albumin excretion rate in Type 1 (insulin-dependent) diabetic patients. Diabetologia 1993; 47: 1045-1050.
5. Jensen T. Albuminuria: a marker of renal and generalised vascular disease in insulin-dependent diabetes mellitus. Dan Med Bull 1991; 38: 134-144.
6. Vucovich TC, Scherthaner G, Knobi PN, Hay V. The effect of near-normoglycaemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients. J Clin Endocrinol Metab 1989; 69: 84-89.
7. Holtet TL, Graversen JH, Clemmensen I, Thogersen HC, Etzerodt M. Tetranectin, a trimeric plasminogen-binding C-type lectin. Protein Science 1997; 6: 1511-1515.
8. Hogdall CK, Hogdall EVS, Hording U, Clemmensen I, Norgaard-Pedersen B, Toftager-Larsen K. Preoperative plasma tetranectin as a prognostic marker in ovarian cancer patients. Scand J Clin Lab Invest 1993; 53: 741-746.
9. Christensen L, Clemmensen I. Tetranectin immunoreactivity in normal human tissues. Histochemistry 1989; 92: 29-35.
10. Kluft C, Los P, Clemmensen I. Calcium-dependent binding of tetranectin to fibrin. Thromb Res 1989; 55: 233-238.
11. De Vries TJ, De Wit PE, Clemmensen et al. Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol 1996; 179: 260-265.
12. Jilma B, Fasching P, Ruthner C et al Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996; 76: 328-332.
13. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3-6.
14. Terry RW, Knee L, Levine JF, Labow MA. Cytokine induction of an alternatively spliced vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositolanchored VCAM protein. Proc Natl Acad Sci 1993; 90: 5919-5923.
15. Bennet PH. The diagnosis of diabetes: new international classification and diagnostic diagnostic criteria. Annu Rev Med 1983; 34: 295-309.
16. Kamper EF, Kopeikina LT, Koutsoukos V, Stavridis J. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis. J Rheumatol 1997; 24: 262-268.
17. Hogdall CK, Christiansen L, Clemmensen I. The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer 1993; 72: 2415-2422.
18. Kamper EF, Kopeikina LT, Mantas A, Stefanadis C, Toutouzas P, Stavridis J. Tetranectin levels in patients with acute myocardial infarction and their alternations during thrombolytic treatment. Ann Clin Biochem 1998; 35: 400-407.
19. Kopeikina LT, Kamper EF, Mantas A, Kremastinos D, Stavridis J. Plasma tetranectin levels in patients with unstable and stable angina. Fibrinolysis & Proteolysis 1998; 12: 353-359.
20. Kamper EF, Kopeikina LT, Trontzas P, Vaiopoulos G, Stavridis J. Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis. Clin Rheumatol 1998; 17: 318-327.
21. Christensen L, Clemmensen I. Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry 1989; 92: 29-35.
22. Kitabchi AE, Duckworth WC, Frankie BS. Insulin synthesis, proinsulin and C-peptide. In: Rifkin H, Porte D, eds. Ellenbery and Rifkin's diabetes mellitus. Theory and practice, 4th edn. New York: Elsevier, 1990: 71-88.
23. Yokoyama H, Deckert T. Central role of TCP-beta in the pathogenesis of diabetic nephropathy and macrovascular complication: a hypothesis. Diabet Med 1996; 13: 313-320.
24. Shield JP, Carradus M, Stone JE, Hunt I.P, Baum JD, Pennock CA. Urinary heparan sulphate proteoglycan excretion. Ann Clin Biochem 1995; 32: 557-560.